FDA Grants Vical Orphan Drug Designation for VL-2397 for the Treatment of Invasive Aspergillosis
January 06, 2016 06:30 ET
|
Vical Incorporated
SAN DIEGO, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL), a biotechnology company developing vaccines and therapeutics for prevention and treatment of infectious diseases,...
Vical Appoints Dr. Thomas Shenk to Board of Directors
December 21, 2015 16:15 ET
|
Vical Incorporated
SAN DIEGO, Dec. 21, 2015 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL), a biotechnology company developing vaccines and therapeutics for prevention and treatment of infectious diseases,...
Vical to Present at the Stifel Healthcare Conference 2015
November 11, 2015 08:00 ET
|
Vical Incorporated
SAN DIEGO, Nov. 11, 2015 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook on...
Vical Reports Third Quarter 2015 Financial Results and Progress in Key Development Programs
October 29, 2015 06:30 ET
|
Vical Incorporated
SAN DIEGO, Oct. 29, 2015 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial results for the three and nine months ended September 30, 2015. Net loss for the third quarter of...
Vical Announces News Release and Conference Call Schedule for Third Quarter 2015 Financial Results
October 22, 2015 06:30 ET
|
Vical Incorporated
SAN DIEGO, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will report financial results for the three and nine months ended September 30, 2015,...
Vical to Present Preclinical Data at ICAAC 2015 Meeting for Its Novel Antifungal Drug Candidate VL-2397
September 15, 2015 06:30 ET
|
Vical Incorporated
SAN DIEGO, Sept. 15, 2015 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL), a biotechnology company developing vaccines and therapeutics for prevention and treatment of infectious diseases, today...
Vical to Present at the Rodman & Renshaw 17th Annual Global Investment Conference
September 03, 2015 16:30 ET
|
Vical Incorporated
SAN DIEGO, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook on...
FDA Grants Qualified Infectious Disease Product (QIDP) Designation to VL-2397, Vical's Antifungal Product Candidate
August 19, 2015 06:30 ET
|
Vical Incorporated
SAN DIEGO, Aug. 19, 2015 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL), a biotechnology company developing vaccines and therapeutics for prevention and treatment of infectious diseases, today...
Vical Reports Second Quarter 2015 Financial Results and Progress in Key Development Programs
July 30, 2015 06:30 ET
|
Vical Incorporated
SAN DIEGO, July 30, 2015 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial results for the three and six months ended June 30, 2015. Net loss for the second quarter of 2015...
Vical Announces News Release and Conference Call Schedule for Second Quarter 2015 Financial Results
July 23, 2015 06:30 ET
|
Vical Incorporated
SAN DIEGO, July 23, 2015 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will report financial results for the three and six months ended June 30, 2015, before...